Topology and Form Finding via Genetic Algorithms

The following presents an approach to early applications of the Galapagos program as a means to optimize structural forms. The process was conducted with Rhino’s Grasshopper program, the structural analysis plug-in, Karamba, and the genetic algorithm solver, Galapagos. This topological form finding process was based on flexible parameters that modified brace and column locations, and diaphragm size and positions. This process worked by having Galapagos modify a parametric model which had initial randomly generated variables for the genomes. After structural analysis, Galapagos was tasked with changing the form in order to minimize overall displacement of the structure. Being an evolutionary solver, Galapagos creates a “population” of solutions and eliminates non-effective offspring to continue breeding effective offspring through multiple generations. This means that solutions found through Galapagos were best fit to the program, but were not necessarily an absolute perfect solution, as that could take hundreds of generations to find. This also means solutions vary based on the beginning placement of genomes before populations are created. However, after comparing Galapagos to what was intuited and what are known structural solutions, there is a strong case to be made that Grasshopper, Karamba, and Galapagos can be used effectively in engineering practice to create both beautiful and efficient structures

Assessing Spiritual Development in Business Students: Lessons Learned and a Suggested Process

As Christian higher education institutions increasingly engage in continuous quality improvement and outcome measurement, research on spiritual development is filtering down to undergraduate business programs. This paper presents lessons learned from a pilot cross-sectional survey of Abilene Christian University undergraduate business students who completed the Faith Maturity Scale (Benson, Donahue & Erickson, 1993) and responded to other questions about faith development. Based on the results, a number of helpful observations were made for the ACU business program. A method and process for assessing spiritual development at multiple Christian colleges is proposed

Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis

Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Balance studies for nitrogen, potassium, magnesium, phosphorus, and calcium were carried out in eight men undergoing continuous ambulatory peritoneal dialysis (CAPD) to determine dietary protein requirements and mineral balances. Patients were fed high energy diets for 14 to 33 days which provided either 0.98 (seven studies) or 1.44g (six studies) of primarily high biological value protein/kg body wt/day. Mean nitrogen balance was neutral with the lower protein diet (+0.35 ± 0.83SEMg/day) and strongly positive with the higher protein diet (+2.94 ± 0.54g/day). With the higher protein diet the balances for potassium, magnesium, and phosphorus were strikingly positive, there was an increase in body weight in all patients, and a rise in mid-arm muscle circumference in five of the six patients. The relation between protein intake and nitrogen balance suggests that the daily protein requirement for clinically stable CAPD patients should be at least 1.1g/kg/day; to account for variability among subjects 1.2 to 1.3g protein/kg/day is probably preferable. Potassium balance correlated directly with nitrogen balance (r = 0.81). High fecal potassium losses (19 ± 1.2 mEq/day) in all patients probably helped maintain normal serum potassium concentrations. Mean serum magnesium was increased (3.1 ± 0.1 mg/dl), and magnesium balances were positive suggesting that the dialysate magnesium of 1.85 mg/dl is excessive. The netgain of calcium from dialysate was 84 ± 18 mg/day; this correlated inversely with serum calcium levels (r = -0.90).Bilans métaboliques et besoins protéiques alimentaires de malades en dialyse péritonéale continue ambulatoire. Des études de bilan de l'azote, du potassium, du magnésium, du phosphore et du calcium, étaient fait en sept hommes en dialyse péritonéale continue ambulatoire (CAPD), pour déterminer leurs besoins protéiques alimentaires et leur bilan minéral. Les malades ont reçu pendant 14 à 33 jours des régimes hautement énergétiques, apportant soit 0,98 (sept études), soit 1,44g (six études) de protéines de haute valeur biologique par kg de poids et par jour. Le bilan azoté moyen etait nul avec le régime comportant la plus faibie teneur protéique (+ 0,35 ± 0,88g/jSEM) et était fortement positive avec le régime à plus forte teneur protéique (+2,94 ± 0,54g/j). Avec le régime à haute teneur en protéine, les bilans potassique, magnésien et phosphoré étaient fortement positifs; le poids corporel s'est élevé chez tous les malades; la circonférence musculaire mesurée du milieu du bras a augmenté chez cinq sur six malades. La relation existant entre l'apport protéique et le bilan azoté suggère que les besoins journaliers en protéines pour des malades cliniquement stables en CAPD devraient être au moins de 1,1g/kg/j; 1,2 à 1,3g de protéines/kg/j sont sans doute préférables pour tenir compte de la variabilité entre les sujets. Le bilan potassique était directement corrélé avec la balance azotée (r = 0,81). De fortes pertes potassiques fécales (19 ± 1,2 mEq/j) chez tous les malades ont probablement contribué à maintenir normales les concentrations sériques du potassium. La magnésémie moyenne était élevée (3,1 ± 0,1 mg/dl), et les bilans magnésiens aient positifs suggérant que le magnésium du dialysat (1,85 18 mg/dl) était trop élevé. Le gain net en calcium à partir du dialysat était de 84 ± 18 mg/j; ce gain était inversement corrélé avec la calcémie (r = 0,90)

Effects of Acute Late Sleep Restriction on Strength, Power, and Running Speed in Recreationally Active Females

Previous research suggests that late sleep restriction (SR) paired with exercise in the morning does not have a significant impact on sport performance measures. However, this evidence is based on research conducted primarily in males. PURPOSE: To examine the effects of late sleep restriction on measures of strength, speed, and power among recreationally active females. METHODS: Twenty-three (23) recreationally active (aerobic physical activity and resistance exercise at least three times a week for six months) females participated in this study (mean age 21.5 years, BMI 23 kg/m2). A randomized, cross-over design was used under two conditions, recommended sleep (RS), and late SR. Participants performed three exercises to obtain measures; Isometric mid-thigh-pull (Relative Peak Force [RPF], Peak Force [PF], Rate of Force Development [RFD]), 20-yard sprint (time in seconds), and Counter-movement jump (Jump Height [JH], Relative Peak Power [RPP]). Conditions were separated with a 3-day resting period. For RS, participants were instructed to achieve 7h of sleep which align with the recommendation for healthy sleep length. For SR, participants subtracted three hours of sleep from the usual wake-up time with at least three hours of awake time before testing. RESULTS: No significant differences were found comparing RS and SR for all measures. CONCLUSION: Late SR did not affect measures of strength, speed, and power among recreationally active female athletes when compared to RS. These results support former research suggesting no evidence of impaired performance for strength, power, or speed with a single bout of late sleep restriction and exercise in the morning. Previous research suggests that psychomotor functioning may be affected in a greater way than gross motor functioning. Therefore, future research should consider effects of multiple, consecutive bouts of SR on performance measures as well as psychomotor functioning specifically in females

Glucose absorption during continuous ambulatory peritoneal dialysis

Glucose absorption during continuous ambulatory peritoneal dialysis. Patients undergoing continuous ambulatory peritoneal dialysis (CAPD) are exposed to a continuous infusion of glucose via their peritoneal cavity. We performed studies to quantitate the amount of energy derived from dialysate glucose. Net glucose absorption averaged 182 ± (SD) 61 g/day in 19 studies with a dialysate dextrose concentration of 1.5 or 4.25 g/dl. The amount of glucose absorbed per liter of dialysate (y) varied with the concentration of glucose in dialysate (x), (y = 11.3x - 10.9, r = 0.96), The amount of glucose absorbed per day during a given dialysis regimen was constant. Energy intake from dialysate glucose was 8.4 ± 2.8 kcal/kg of body wt per day, or 12 to 34% of total energy intake. This additional energy may contribute to the anabolic effect reported during CAPD. The ability to vary glucose absorption by altering the dialysate glucose concentration may prove a useful tool to modify energy intake.Absorption de glucose au cours de la dialyse péritonéale continue ambulatoire. Les malades soumis à la dialyse péritonéale continue ambulatoire (CAPD) sont exposés à une administration continue de glucose via leur cavité péritonéale. La quantité d'énergie qui dérive du glucose du dialysat a été quantifiée. L'absorption nette de glucose est en moyenne de 182 ± (SD) 61 g/jour au cours de 19 études avec un dialysat contenant du dextrose, 1,5 ou 4,25 g/dl. La quantité de glucose absorbée par litre de dialysat (y) varie avec la concentration de glucose dans le dialysat (x), (y = 11,3x - 10,9, r = 0,96). La quantité de glucose absorbée par jour pour un type donné de dialyse a été constante. L'entrée d'énergie à partir du glucose du dialysat était de 8,4 ± 2,8 kcal/kg de poids par jour, soit 12 à 34% de l'entrée totale d'énergie. Cette énergie supplémentaire peut contribuer à l'effet anabolique rapporté au cours de CAPD. La possibilité de faire varier l'absorption de glucose en modifiant la concentration de glucose dans le dialysat peut être un moyen utile pour influencer l'entrée d'énergie

Development of the combined method of hardening of the surface of aluminium

Представлены результаты, полученные при исследовании фазового и элементного состава, дефектной субструктуры поверхности технически чистого алюминия марки А7, подвергнутого комбинированной обработке, сочетающей напыление металлической пленки, электронно-пучковое перемешивание системы пленка/подложка и последующее азотирование в плазме газового разряда низкого давления. Выполнен анализ закономерностей, выявлены режимы воздействия, позволяющие кратно повышать микротвердость и износостойкость материала.The results are presented, received at research of phase and elemental composition, defective substructureof surface technically pure aluminium of the A7, subjected to the combined processing combining spraying metalfilm, electron-beam mixing of system film/substrate and subsequent nitriding in plasma of the gas discharge of lowpressure. The analysis of regularities is made, revealed the modes of influence allowing multiple to raise amicrohardness and wear resistance of material

Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice.

BackgroundAlzheimer disease (AD) is characterized by the accumulation of beta-amyloid (Aβ) plaques and neurofibrillary tangles composed of hyperphosphorylated tau, which together lead to neurodegeneration and cognitive decline. Current therapeutic approaches have primarily aimed to reduce pathological aggregates of either Aβ or tau, yet phase 3 clinical trials of these approaches have thus far failed to delay disease progression in humans. Strong preclinical evidence indicates that these two abnormally aggregated proteins interact synergistically to drive downstream neurodegeneration. Therefore, combinatorial therapies that concurrently target both Aβ and tau might be needed for effective disease modification.MethodsA combinatorial vaccination approach was designed to concurrently target both Aβ and tau pathologies. Tau22/5xFAD (T5x) bigenic mice that develop both pathological Aβ and tau aggregates were injected intramuscularly with a mixture of two MultiTEP epitope vaccines: AV-1959R and AV-1980R, targeting Aβ and tau, respectively, and formulated in AdvaxCpG, a potent polysaccharide adjuvant. Antibody responses of vaccinated animals were measured by ELISA, and neuropathological changes were determined in brain homogenates of vaccinated and control mice using ELISA and Meso Scale Discovery (MSD) multiplex assays.ResultsT5x mice immunized with a mixture of Aβ- and tau-targeting vaccines generated high Aβ- and tau-specific antibody titers that recognized senile plaques and neurofibrillary tangles/neuropil threads in human AD brain sections. Production of these antibodies in turn led to significant reductions in the levels of soluble and insoluble total tau, and hyperphosphorylated tau as well as insoluble Aβ42, within the brains of bigenic T5x mice.ConclusionsAV-1959R and AV-1980R formulated with AdvaxCpG adjuvant are immunogenic and therapeutically potent vaccines that in combination can effectively reduce both of the hallmark pathologies of AD in bigenic mice. Taken together, these findings warrant further development of this vaccine technology for ultimate testing in human AD

Ultrasonic propulsion of kidney stones: preliminary results of human feasibility study

One in 11 Americans has experienced kidney stones, with a 50% average recurrence rate within 5-10 years. Ultrasonic propulsion (UP) offers a potential method to expel small stones or residual fragments before they become a recurrent problem. Reported here are preliminary findings from the first investigational use of UP in humans. The device uses a Verasonics ultrasound engine and Philips HDI C5-2 probe to generate real-time B-mode imaging and targeted "push" pulses on demand. There are three arms of the study: de novo stones, post-lithotripsy fragments, and the preoperative setting. A pain questionnaire is completed prior to and following the study. Movement is classified based on extent. Patients are followed for 90 days. Ten subjects have been treated to date: three de novo, five post-lithotripsy, and two preoperative. None of the subjects reported pain associated with the treatment or a treatment related adverse event, beyond the normal discomfort of passing a stone. At least one stone was moved in all subjects. Three of five post-lithotripsy subjects passed a single or multiple stones within 1-2 weeks following treatment; one subject passed two (1-2 mm) fragments before leaving clinic. In the pre-operative studies we successfully moved 7 - 8 mm stones. In four subjects, UP revealed multiple stone fragments where the clinical image and initial ultrasound examination indicated a single large stone